Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.25%
)
US TECH 100
24,300.80
(
0.70%
)
Dow Jones
46,993.26
(
0.10%
)
Brent Oil
99.90
(
-0.75%
)
Bitcoin
74,033.85
(
0.12%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

turtlepower

Send PM Follow Ignore
Followers 1
Posts 1114
Boards Moderated 0
Alias Born 04/07/2009

turtlepower

Re: DewDiligence post# 97437

Friday, 10/08/2010 8:17:24 AM

Friday, October 08, 2010 8:17:24 AM

Post# of 257253
Boehringer Ends Female Desire Drug Development After FDA's Safety Query
By Naomi Kresge - Oct 8, 2010 3:55 AM ET
Tweet LinkedIn Share Print Email
Oct. 8 (Bloomberg) - Boehringer Ingelheim GmbH abandoned development of its female desire drug flibanserin after U.S. regulators said the pill wasn’t proven to be safe and effective.

<snip>
http://www.bloomberg.com/news/2010-10-08/boehringer-ends-female-desire-drug-development-after-fda-s-safety-query.html?
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now